Receptors for kinins: From classical pharmacology to molecular biology
Reference (33)
- et al.
Hydrogen peroxide an endogenous smooth muscle cell hyperpolarizing factor
Biochem Biophys Res Commun
(1991) - et al.
In vitro effects of HOE 140 in human bronchial and vascular tissue
Eur J Pharmacol
(1995) - et al.
Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
Biochem Biophys Res Commun
(1992) - et al.
Cloning and pharmacological characterization of a rabbit bradykinin B1 receptor
Biochim Biophys Acta
(1995) - et al.
Expression and cloning of a human B-1 bradykinin receptor
J Biol Chem
(1994) - et al.
Bradykinin receptor types and B2 subtypes
Life Sci
(1994) - et al.
Receptors for kinins in isolated arterial vessels of dogs
Eur J Pharmacol
(1989) - et al.
Competitive antagonists of bradykinin
Peptides
(1985) - et al.
Bradykinin-induced relaxation of renal and pulmonary arteries is dependent upon intact endothelial cells
Br J Pharmacol
(1981) - et al.
Cardiovascular actions of kinins in the rabbit
Can J Physiol Pharmacol
(1978)
The dog carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins
Can J Physiol Pharmacol
The requirements for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators
TIPS
Reactions of strips of rabbit aorta to epinephrine, isoproterenol, sodium nitrite and other drugs
J Pharmacol Exp Ther
Pharmacological studies of kinins in venous smooth muscles
Can J Physiol Pharmacol
Characterization of kinin receptors by bioassays
Braz J Med Biol Res
Cited by (14)
Neuroprotective effects of a postischemic treatment with a bradykinin B<inf>2</inf> receptor antagonist in a rat model of temporary focal cerebral ischemia
2006, Brain ResearchCitation Excerpt :A constitutive expression of cerebral B2 receptors has been confirmed in cortical and striatal neurons, which both belong to brain areas severely affected after a focal cerebral insult (Chen et al., 2000; Raidoo and Bhoola, 1997; Takano et al., 1999). B2 receptor activation induces the release of inflammatory mediators such as reactive oxygen radicals (Rosenblum, 1987; Sobey et al., 1997), nitric oxide (Gorlach and Wahl, 1996; Gunnett et al., 2002; Regoli et al., 1996), prostanoids (Easton and Abbott, 2002; Gecse et al., 1989), and cytokines (Schwaninger et al., 1999). This ultimately leads to vasodilation, increase of vascular permeability, blood–brain barrier disruption, and cerebral edema (Ellis et al., 1987; Kamitani et al., 1985; Plesnila et al., 2001; Unterberg et al., 1984; Wahl et al., 1983).
Novel small molecule bradykinin B<inf>2</inf> receptor antagonists
2009, Journal of Medicinal Chemistry